演讲的主题是：国家胸痛中心--经验分享和介入技术发展
演讲分为两个部分，分别是中国胸痛中心建设的经验和介入技术的发展。
演讲的主要内容如下：
1. 胸痛中心建设经验主要包括：胸痛中心建设理论、标准、五大要素要求和组织管理模式，同时阐述了胸痛中心建设对提高医疗机构综合能力的作用。
2. 中国介入技术的发展主要包括：
- 2009年至2023年中国大陆心血管介入技术的普及、发展，胸痛中心体系建设与PCI技术提升相互促进，取得积极成效
- 从数据角度回顾发展：
* 建立了全国急性胸痛治疗网络，
* 胸痛中心的建设显著提高了心血管病医院的专业能力，
* 基层单位心血管疾病救治能力显著提升
The topic of the speech is The National Chest Pain Center – Experience Sharing and the Development of Interventional Technology.
The speech is divided into two parts, which are experience in constructing chest pain centers and development of interventional techniques in China.
The main contents of the speech are following:
1) The experience of chest pain center construction mainly includes the theory of chest pain center construction, standards, five elements requirements and organizational management mode, and expounds the role of chest pain center construction in improving the comprehensive ability of medical institutions.
2) The development of interventional technology in China mainly includes：
- PCI Case Number from 2009 to 2023
- PCI Case Growth Rate from 2010 to 2023
- Cases per Million in Population in Each Province/Municipality/Autonomous Region in 2023
- Number of STEMI and Direct PCI Cases from 2009 to 2023
- Proportion of Direct PCI Cases from 2009 to 2023
- Coronary interventions in county-level hospitals are growing rapidly 2019 VS 2023
- County-Level Hospitals VS Non-County-Level Hospitals
- Reviewing Development from the Data Perspective:
Establishment of a National Treatment Network for Acute Chest Pain, The Number of County-Level Hospitals with Certified Chest Pain Centers Continues to Grow Nationwide，The Number of County-Level Hospitals Adopting PCI as the Primary Reperfusion Strategy Continues to Grow，The Construction of Chest Pain Centers Significantly Enhances the Specialty Capabilities of Cardiovascular Hospitals，The Number of Acute High-Risk Chest Pain Patients Treated at District- and County-Level Chest Pain Centers Continues to Grow Over the Past Five Years，Treatment Efficiency in County-Level Hospitals Continues to Increase.
